Figure 7.
Figure 7. Transfer of NeuACE neutrophils into immunosuppressed mice increased resistance to MRSA infection. WT mice were made neutropenic with cyclophosphamide (230 mg per mouse, single IP dose). Mice were divided into 3 groups, and 1 day after drug injection, the mice were challenged subcutaneously with MRSA (3 × 106 CFU). Two days after drug injection, mice received 107 neutrophils of IV purified from bone marrow of either WT or NeuACE mice. One group of mice received PBS only. (A) Skin lesion area and (B) bacterial counts in skin lesions (B) were measured 3 days after MRSA infection. *P ≤ .05, **P ≤ .005, ***P ≤ .0005.

Transfer of NeuACEneutrophils into immunosuppressed mice increased resistance to MRSA infection. WT mice were made neutropenic with cyclophosphamide (230 mg per mouse, single IP dose). Mice were divided into 3 groups, and 1 day after drug injection, the mice were challenged subcutaneously with MRSA (3 × 106 CFU). Two days after drug injection, mice received 107 neutrophils of IV purified from bone marrow of either WT or NeuACE mice. One group of mice received PBS only. (A) Skin lesion area and (B) bacterial counts in skin lesions (B) were measured 3 days after MRSA infection. *P ≤ .05, **P ≤ .005, ***P ≤ .0005.

Close Modal

or Create an Account

Close Modal
Close Modal